Stocks and Investing Stocks and Investing
Tue, November 7, 2017
Mon, November 6, 2017
Fri, November 3, 2017
Thu, November 2, 2017

Rahul Jasuja Maintained (ALNY) at Strong Buy with Increased Target to $240 on, Nov 2nd, 2017


Published on 2024-10-26 00:24:00 -
  Print publication without navigation


Rahul Jasuja of FBR Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy with Increased Target from $150 to $240 on, Nov 2nd, 2017.

Rahul has made no other calls on ALNY in the last 4 months.



There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 2 agree with Rahul's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Paul Matteis of "Leerink Swann" Maintained at Hold with Increased Target to $112 on, Thursday, September 21st, 2017
  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Increased Target to $101 on, Thursday, September 21st, 2017


These are the ratings of the 6 analyists that currently disagree with Rahul


  • Terence Flynn of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Monday, October 2nd, 2017
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $134 on, Friday, September 22nd, 2017
  • Geoff Meacham of "Barclays" Maintained at Buy with Increased Target to $127 on, Thursday, September 21st, 2017
  • Alan Carr of "Needham" Maintained at Strong Buy with Increased Target to $125 on, Thursday, September 21st, 2017
  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $123 on, Thursday, September 21st, 2017
  • Christopher Marai of "Nomura" Initiated at Sell and Held Target at $56 on, Friday, September 15th, 2017